申请人:The Research Foundation of State University of New York
公开号:US06407288B1
公开(公告)日:2002-06-18
The present invention discloses novel naphthylsalicylanilides of the general formula
wherein W is a substituted or unsubstituted naphthyl ring. The substitution on W includes replacing one or more —H with —OH, alkyl, O-alkyl, branched alkyl, or cycloalkyl, containing 1-6 carbon atoms or combinations thereof. Y is a substituted or unsubstituted phenyl ring or substituted or unsubstituted naphthyl ring. The substitution for Y includes replacement of one or more —H atoms with CN, CF3, NO2, methoxy, benzoyl, phenoxy, phenoxymethyl or combinations thereof. These compounds are useful as antibacterial against gram negative and gram positive bacteria and as antiinflammatory agents.
本发明揭示了一种新型的萘基水杨酰苯胺,其一般式如下:其中W是取代或未取代的萘环。W上的取代包括用—OH、烷基、O-烷基、支链烷基或环烷基替换一个或多个—H,其中烷基、O-烷基、支链烷基或环烷基含有1-6个碳原子或其组合。Y是取代或未取代的苯环或取代或未取代的萘环。Y的取代包括用CN、CF3、NO2、甲氧基、苯甲酰基、苯氧基、苯氧甲基或其组合替换一个或多个—H原子。这些化合物可用作抗革兰氏阴性和革兰氏阳性细菌的抗菌剂,以及作为抗炎药。